Mark G Currie Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark G Currie.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark G Currie. Mark G Currie is Chief Scientific Officer in IRONWOOD PHARMACEUTICALS INC ($IRWD) and Director in IRONWOOD PHARMACEUTICALS INC ($IRWD) and President in Cyclerion Therapeutics, Inc. ($CYCN) and President and CSO in Cyclerion Therapeutics, Inc. ($CYCN).
Latest Insider Trading Transactions of Mark G Currie
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Sell | S | 11.59 | 23,571 | 273,188 | 570,187 | 593.8 K to 570.2 K (-3.97 %) |
| Dec 30 2020 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President and CSO | Sell | S | 3.01 | 20,107 | 60,522 | 251,648 | 271.8 K to 251.6 K (-7.40 %) |
| Jun 05 2020 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Grant | A | 0.00 | 21,720 | 0 | 570,992 | 549.3 K to 571 K (+3.95 %) |
| Jan 24 2020 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | M | 9.12 | 60,000 | 547,200 | 47,707 | |
| Jan 24 2020 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Sell | S | 12.59 | 60,000 | 755,400 | 549,272 | 609.3 K to 549.3 K (-9.85 %) |
| Jan 24 2020 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Buy | M | 9.12 | 60,000 | 547,200 | 609,272 | 549.3 K to 609.3 K (+10.92 %) |
| Jan 21 2020 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | M | 10.02 | 8,888 | 89,058 | 0 | |
| Jan 21 2020 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Sell | S | 12.80 | 8,888 | 113,766 | 549,272 | 558.2 K to 549.3 K (-1.59 %) |
| Jan 21 2020 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Buy | M | 10.02 | 8,888 | 89,058 | 558,160 | 549.3 K to 558.2 K (+1.62 %) |
| Dec 31 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Sell | S | 2.48 | 25,000 | 62,000 | 271,755 | 296.8 K to 271.8 K (-8.42 %) |
| Dec 31 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Sell | S | 2.55 | 25,000 | 63,750 | 296,755 | 321.8 K to 296.8 K (-7.77 %) |
| Dec 18 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Gift | G | 0.00 | 500 | 0 | 549,272 | 549.8 K to 549.3 K (-0.09 %) |
| Dec 18 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Gift | G | 0.00 | 1,837 | 0 | 549,772 | 551.6 K to 549.8 K (-0.33 %) |
| Nov 26 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 2.01 | 75,000 | 150,750 | 75,000 | |
| May 31 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Grant | A | 0.00 | 22,706 | 0 | 551,609 | 528.9 K to 551.6 K (+4.29 %) |
| May 14 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Sell | S | 10.53 | 4,055 | 42,699 | 528,903 | 533 K to 528.9 K (-0.76 %) |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 14.20 | 514,786 | 7,309,961 | 514,786 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 16.02 | 141,007 | 2,258,932 | 141,007 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 18.46 | 113,430 | 2,093,918 | 113,430 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 11.28 | 50,801 | 573,035 | 50,801 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 17.20 | 2,500 | 43,000 | 2,500 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 17.20 | 13,125 | 225,750 | 13,125 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 15.54 | 9,930 | 154,312 | 9,930 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 14.40 | 27,773 | 399,931 | 27,773 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 16.21 | 17,491 | 283,529 | 17,491 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 12.23 | 37,286 | 456,008 | 37,286 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 12.39 | 888 | 11,002 | 888 | |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Buy | P | 14.81 | 270,107 | 4,000,285 | 321,755 | 51.6 K to 321.8 K (+522.98 %) |
| Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Grant | A | 0.00 | 51,648 | 0 | 51,648 | 0 to 51.6 K |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 11.49 | 562,500 | 6,463,125 | 37,500 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 12.95 | 147,813 | 1,914,178 | 67,187 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 14.93 | 109,375 | 1,632,969 | 140,625 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 9.12 | 44,063 | 401,855 | 107,707 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 12.56 | 1,771 | 22,244 | 83,229 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 11.65 | 9,617 | 112,038 | 190,383 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 13.11 | 8,029 | 105,260 | 101,971 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 15.62 | 25,000 | 390,500 | 0 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 11.11 | 41,041 | 455,966 | 0 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Option Exercise | D | 5.48 | 20,000 | 109,600 | 0 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Grant | A | 0.00 | 2,995 | 0 | 532,958 | 530 K to 533 K (+0.57 %) |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Director | Grant | A | 0.00 | 1,483 | 0 | 529,963 | 528.5 K to 530 K (+0.28 %) |
| Mar 08 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 13.15 | 49,500 | 650,925 | 528,480 | 578 K to 528.5 K (-8.56 %) |
| Mar 08 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 13.29 | 225,500 | 2,996,895 | 577,980 | 803.5 K to 578 K (-28.07 %) |
| Feb 22 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 14.32 | 13 | 186 | 803,480 | 803.5 K to 803.5 K (0.00 %) |
| Feb 22 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 14.31 | 1,631 | 23,340 | 803,493 | 805.1 K to 803.5 K (-0.20 %) |
| Jan 31 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 12.90 | 600,000 | 7,740,000 | 600,000 | |
| Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | J | 5.48 | 20,000 | 109,600 | 20,000 | |
| Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | J | 5.48 | 20,000 | 109,600 | 0 | |
| Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | J | 0.00 | 775,000 | 0 | 805,124 | 30.1 K to 805.1 K (+2,572.70 %) |
| Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | J | 0.00 | 775,000 | 0 | 0 | 775 K to 0 (-100.00 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 10.24 | 41,615 | 426,138 | 151,770 | |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 11.11 | 34,480 | 383,073 | 41,041 | |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 11.25 | 40,556 | 456,255 | 8,888 | |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 10.24 | 41,615 | 426,138 | 193,385 | |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 11.11 | 34,479 | 383,062 | 75,521 | |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 11.25 | 40,556 | 456,255 | 49,444 | |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 17.53 | 116,651 | 2,044,892 | 30,124 | 146.8 K to 30.1 K (-79.48 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 10.24 | 41,615 | 426,138 | 146,775 | 105.2 K to 146.8 K (+39.57 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 11.11 | 34,480 | 383,073 | 105,160 | 70.7 K to 105.2 K (+48.78 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 11.25 | 40,556 | 456,255 | 70,680 | 30.1 K to 70.7 K (+134.63 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 18.75 | 22,194 | 416,138 | 30,124 | 52.3 K to 30.1 K (-42.42 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 17.94 | 94,456 | 1,694,541 | 52,318 | 146.8 K to 52.3 K (-64.35 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 10.24 | 41,615 | 426,138 | 146,774 | 105.2 K to 146.8 K (+39.57 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 11.11 | 34,479 | 383,062 | 105,159 | 70.7 K to 105.2 K (+48.78 %) |
| Oct 09 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 11.25 | 40,556 | 456,255 | 70,680 | 30.1 K to 70.7 K (+134.63 %) |
| Aug 28 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 5.48 | 6,666 | 36,530 | 20,000 | |
| Aug 28 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 4.89 | 41,667 | 203,752 | 0 | |
| Aug 28 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 4.89 | 16,667 | 81,502 | 0 | |
| Aug 28 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 18.39 | 65,000 | 1,195,350 | 775,000 | 840 K to 775 K (-7.74 %) |
| Aug 28 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 5.48 | 6,666 | 36,530 | 840,000 | 833.3 K to 840 K (+0.80 %) |
| Aug 28 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 4.89 | 41,667 | 203,752 | 833,334 | 791.7 K to 833.3 K (+5.26 %) |
| Aug 28 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 4.89 | 16,667 | 81,502 | 791,667 | 775 K to 791.7 K (+2.15 %) |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 5.48 | 6,667 | 36,535 | 26,666 | |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 4.89 | 41,666 | 203,747 | 41,667 | |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 4.89 | 16,667 | 81,502 | 16,667 | |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 5.48 | 6,667 | 36,535 | 33,333 | |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 4.89 | 41,667 | 203,752 | 83,333 | |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 4.89 | 16,666 | 81,497 | 33,334 | |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 18.39 | 65,000 | 1,195,350 | 775,000 | 840 K to 775 K (-7.74 %) |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 5.48 | 6,667 | 36,535 | 840,000 | 833.3 K to 840 K (+0.80 %) |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 4.89 | 41,666 | 203,747 | 833,333 | 791.7 K to 833.3 K (+5.26 %) |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 4.89 | 16,667 | 81,502 | 791,667 | 775 K to 791.7 K (+2.15 %) |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 18.51 | 65,000 | 1,203,150 | 775,000 | 840 K to 775 K (-7.74 %) |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 5.48 | 6,667 | 36,535 | 840,000 | 833.3 K to 840 K (+0.80 %) |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 4.89 | 41,667 | 203,752 | 833,333 | 791.7 K to 833.3 K (+5.26 %) |
| Aug 24 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 4.89 | 16,666 | 81,497 | 791,666 | 775 K to 791.7 K (+2.15 %) |
| Aug 02 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Grant | A | 0.00 | 12,000 | 0 | 30,124 | 18.1 K to 30.1 K (+66.21 %) |
| Feb 22 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 14.55 | 215,000 | 3,128,250 | 215,000 | |
| Feb 22 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 14.66 | 1,634 | 23,954 | 18,124 | 19.8 K to 18.1 K (-8.27 %) |
| Jan 26 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 3.76 | 60,000 | 225,600 | 0 | |
| Jan 26 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 15.45 | 60,000 | 927,000 | 775,000 | 835 K to 775 K (-7.19 %) |
| Jan 26 2018 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 3.76 | 60,000 | 225,600 | 835,000 | 775 K to 835 K (+7.74 %) |
| Dec 11 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Gift | G | 0.00 | 1,500 | 0 | 19,758 | 21.3 K to 19.8 K (-7.06 %) |
| Mar 16 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 3.76 | 60,000 | 225,600 | 60,000 | |
| Mar 16 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 17.06 | 60,000 | 1,023,600 | 775,000 | 835 K to 775 K (-7.19 %) |
| Mar 16 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 3.76 | 60,000 | 225,600 | 835,000 | 775 K to 835 K (+7.74 %) |
| Mar 01 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 16.77 | 250,000 | 4,192,500 | 250,000 | |
| Feb 24 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 16.94 | 1,800 | 30,492 | 21,258 | 23.1 K to 21.3 K (-7.81 %) |
| Jan 20 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 2.94 | 55,987 | 164,602 | 0 | |
| Jan 20 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 2.94 | 55,987 | 164,602 | 775,000 | 719 K to 775 K (+7.79 %) |
| Jan 10 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 2.94 | 34,013 | 99,998 | 55,987 | |
| Jan 10 2017 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 2.94 | 34,013 | 99,998 | 719,013 | 685 K to 719 K (+4.97 %) |
| Dec 08 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Gift | G | 0.00 | 2,500 | 0 | 23,058 | 25.6 K to 23.1 K (-9.78 %) |
| Nov 01 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 2.94 | 300,000 | 882,000 | 0 | |
| Nov 01 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 2.94 | 300,000 | 882,000 | 685,000 | 385 K to 685 K (+77.92 %) |
| Mar 11 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 1.56 | 10,898 | 17,001 | 0 | |
| Mar 11 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 1.56 | 150,000 | 234,000 | 0 | |
| Mar 11 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 1.56 | 10,898 | 17,001 | 385,000 | 374.1 K to 385 K (+2.91 %) |
| Mar 11 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 10.86 | 150,000 | 1,629,000 | 374,102 | 524.1 K to 374.1 K (-28.62 %) |
| Mar 11 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 1.56 | 150,000 | 234,000 | 524,102 | 374.1 K to 524.1 K (+40.10 %) |
| Mar 03 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 10.24 | 235,000 | 2,406,400 | 235,000 | |
| Feb 26 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 1.56 | 150,000 | 234,000 | 150,000 | |
| Feb 26 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 8.53 | 150,000 | 1,279,500 | 374,102 | 524.1 K to 374.1 K (-28.62 %) |
| Feb 26 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 1.56 | 150,000 | 234,000 | 524,102 | 374.1 K to 524.1 K (+40.10 %) |
| Feb 26 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 8.50 | 2,154 | 18,309 | 25,558 | 27.7 K to 25.6 K (-7.77 %) |
| Jan 06 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 1.56 | 64,102 | 99,999 | 10,898 | |
| Jan 06 2016 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 1.56 | 64,102 | 99,999 | 374,102 | 310 K to 374.1 K (+20.68 %) |
| Mar 18 2015 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 15.62 | 25,000 | 390,500 | 25,000 | |
| Mar 18 2015 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 15.62 | 25,000 | 390,500 | 25,000 | |
| Mar 18 2015 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 15.62 | 131,250 | 2,050,125 | 131,250 | |
| Mar 18 2015 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Grant | A | 0.00 | 21,875 | 0 | 26,098 | 4.2 K to 26.1 K (+518.00 %) |
| Feb 23 2015 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 25,000 | 15,000 | 0 | |
| Feb 23 2015 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 15.67 | 25,000 | 391,750 | 310,000 | 335 K to 310 K (-7.46 %) |
| Feb 23 2015 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 25,000 | 15,000 | 335,000 | 310 K to 335 K (+8.06 %) |
Page: 1